Cognition in patients with neuromyelitis optica spectrum disorders: A prospective multicentre study of 217 patients (CogniNMO-Study)

Archive ouverte

Hümmert, Martin, W | Stern, Carlotta | Paul, Friedemann | Duchow, Ankelien | Bellmann-Strobl, Judith | Ayzenberg, Ilya | Schwake, Carolin | Kleiter, Ingo | Hellwig, Kerstin | Jarius, Sven | Wildemann, Brigitte | Senel, Makbule | Berthele, Achim | Giglhuber, Katrin | Luessi, Felix | Grothe, Matthias | Klotz, Luisa | Schülke, Rasmus | Gingele, Stefan | Faiss, Jürgen, H | Walter, Annette | Warnke, Clemens | Then Bergh, Florian | Aktas, Orhan | Ringelstein, Marius | Stellmann, Jan-Patrick | Häußler, Vivien | Havla, Joachim | Pellkofer, Hannah | Kümpfel, Tania | Kopp, Bruno | Trebst, Corinna

Edité par CCSD ; SAGE Publications -

International audience. Background: There is limited and inconsistent information on the prevalence of cognitive impairment in neuromyelitis optica spectrum disorders (NMOSD). Objective: To assess cognitive performance and changes over time in NMOSD. Methods: This study included data from 217 aquaporin-4-IgG-seropositive (80%) and double-seronegative NMOSD patients. Cognitive functions measured by Symbol Digit Modalities Test (SDMT), Paced Auditory Serial-Addition Task (PASAT), and/or Multiple Sclerosis Inventory Cognition (MuSIC) were standardized against normative data (N = 157). Intraindividual cognitive performance at 1-and 2-year follow-up was analyzed. Cognitive test scores were correlated with demographic and clinical variables and assessed with a multiple linear regression model. Results: NMOSD patients were impaired in SDMT (p = 0.007), MuSIC semantic fluency (p < 0.001), and MuSIC congruent speed (p < 0.001). No significant cognitive deterioration was found at followup. SDMT scores were related to motor and visual disability (p Bon < 0.05). No differences were found between aquaporin-4-IgG-seropositive and double-seronegative NMOSD. Conclusions: A subset of NMOSD patients shows impairment in visual processing speed and in semantic fluency regardless of serostatus, without noticeable changes during a 2-year observation period. Neuropsychological measurements should be adapted to physical and visual disabilities.

Suggestions

Du même auteur

Effects of the COVID-19 Pandemic on Patients With NMO Spectrum Disorders and MOG-Antibody–Associated Diseases

Archive ouverte | Hümmert, Martin, W | CCSD

International audience. Background and Objectives To evaluate the effects of the coronavirus disease 2019 (COVID-19) pandemic on the life of patients with neuromyelitis optica spectrum disorders (NMOSD) and myelin o...

Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management

Archive ouverte | Kümpfel, Tania | CCSD

International audience. This manuscript presents practical recommendations for managing acute attacks and implementing preventive immunotherapies for neuromyelitis optica spectrum disorders (NMOSD), a rare autoimmun...

Real-world multicentre cohort study on choices and effectiveness of immunotherapies in NMOSD and MOGAD

Archive ouverte | Häußler, Vivien | CCSD

International audience. Recurrent attacks in neuromyelitis optica spectrum disorders (NMOSDs) or myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) can lead to severe disability. We aimed to ana...

Chargement des enrichissements...